Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen

Trial Profile

Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Pimonidazole (Primary)
  • Indications Squamous cell cancer; Tongue cancer
  • Focus Diagnostic use
  • Acronyms FAITH
  • Most Recent Events

    • 04 Oct 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.
    • 04 Oct 2017 Planned initiation date changed from 1 Jun 2017 to 1 Nov 2017.
    • 14 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top